EXANE DERIVATIVES - IGM BIOSCIENCES INC ownership

IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 80 filers reported holding IGM BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of IGM BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$865,000
-32.6%
480.0%0.00%
Q1 2022$1,283,000
-8.9%
480.0%0.00%
Q4 2021$1,408,000
-55.4%
480.0%0.00%
-100.0%
Q3 2021$3,156,000
-21.2%
480.0%0.00%0.0%
Q2 2021$4,006,000
-93.7%
48
-94.2%
0.00%
-94.4%
Q1 2021$63,880,000
-61.3%
833
-55.5%
0.02%
-63.3%
Q4 2020$165,095,000
+19.6%
1,8700.0%0.05%
+22.5%
Q3 2020$138,017,000
-3.1%
1,870
-4.2%
0.04%
+5.3%
Q2 2020$142,486,000
+55.7%
1,952
+19.8%
0.04%
+46.2%
Q1 2020$91,520,0001,6300.03%
Other shareholders
IGM BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 2,971,542$24,812,3761.18%
GREAT POINT PARTNERS LLC 615,317$5,137,8970.94%
Artal Group S.A. 2,522,244$21,0610.90%
Opaleye Management Inc. 261,000$2,179,3500.71%
Samsara BioCapital, LLC 154,664$1,291,4440.40%
Bruce & Co., Inc. 120,000$1,002,0000.34%
Rhenman & Partners Asset Management AB 200,000$1,670,0000.18%
Eagle Bay Advisors LLC 44,635$372,7020.17%
RA Capital Management 937,500$7,828,1250.15%
Baker Brothers Advisors 3,157,764$26,367,3290.15%
View complete list of IGM BIOSCIENCES INC shareholders